[144] CODEXIS, INC. SEC Filing
Rhea-AI Filing Summary
A holder of the issuer’s common stock has filed a notice of proposed sale under Rule 144 to sell 6,123 shares through Morgan Stanley Smith Barney Executive Financial Services on the NASDAQ, with an indicated aggregate market value of $10,409.10 and an approximate sale date of 01/07/2026.
The shares to be sold come from restricted stock units (RSUs) that vested and settled on 01/01/2026, when the holder acquired 17,450 shares as compensation for services rendered. The filing also notes that 90,324,383 shares of the issuer’s common stock were outstanding, providing context for the size of the planned sale.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for CDXS disclose?
The Form 144 discloses that a holder of the issuer’s common stock plans to sell 6,123 shares on the NASDAQ, with an indicated aggregate market value of $10,409.10 and an approximate sale date of 01/07/2026.
How many CDXS shares are planned to be sold and at what value?
The notice covers a proposed sale of 6,123 shares of common stock, with an indicated aggregate market value of $10,409.10 as stated in the filing.
How were the CDXS shares in the Form 144 acquired?
The securities to be sold were acquired as common stock through RSU vesting and settlement on 01/01/2026, when the holder received 17,450 shares as consideration for services rendered.
What is the outstanding share count referenced in the CDXS Form 144?
The Form 144 states that there were 90,324,383 shares of the issuer’s common stock outstanding, which helps put the size of the planned sale in context.
Which broker and exchange are involved in the planned CDXS share sale?
The filing lists Morgan Stanley Smith Barney Executive Financial Services as the broker for the transaction, with the shares to be sold on the NASDAQ exchange.
What does the certification section of the Form 144 for CDXS state?
The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, and the form warns that intentional misstatements or omissions can constitute Federal Criminal Violations.